Mölnlycke Health Care is a world leading manufacturer of single-use surgical and wound care products and services to the professional health care sector.
The Surgical Division offers safe and efficient surgical solutions through a number of services and a wide range of high quality single-use surgical products.
The Wound Care division offers a wide range of wound care solutions, including products with Safetac® technology and the Avance™ Negative Pressure Wound Therapy System, providing gentle and effective wound healing to patients and caregivers. Safetac® is available exclusively on Mepitel®, Mepiform®, Mepitac®, and Mepilex®. The Wound Care assortment also has supplementary portfolios in compression, dermatology, and orthopaedics and includes market leading brands such as Mepore and Tubifast, as well as a product for hard-to-heal wounds, Xelma®, an extracellular matrix protein.
Mölnlycke Health Care started operations as an independent company in 1998 and was acquired by Investor in January 2007. The company has about 6700 employees and manufacturing plants in Belgium, the Czech Republic, Finland, France, Malaysia, Thailand, Poland, the UK, and the US.
Mölnlycke Health Care is committed to best practice in wound care.